Cullinan Oncology LLC share price logo

Cullinan Oncology LLC

NASDAQ: CGEM

Small Cap

$15.00

+0.06

(+0.40%)

as on

Cullinan Oncology LLC Stock Performance

as on May 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $14.55
    $15.32
    downward going graph

    3.00%

    Downside

    2.13%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.68
    $16.74
    downward going graph

    62.13%

    Downside

    11.60%

    Upside

    downward going graph

Cullinan Oncology LLC share price movements today

Previous Close
$14.94
Open
$14.83
Volume
575.8K
Day's Low - High
$14.55 - $15.32
52 Week Low - High
$5.68 - $16.74

Cullinan Oncology LLC Historical Returns

1 Month Return
+ 0.13 %
3 Month Return
+ 22.16 %
1 Year Return
+ 90.32 %
3 Year Return
+ 55.95 %
5 Year Return
-48.48 %

Cullinan Oncology LLC Stock Fundamentals & Key Indicators

Check Cullinan Oncology LLC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$942.7M

EPS (TTM)

-3.1261

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-241.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-44.02%

Cullinan Oncology LLC vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cullinan Oncology LLC with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$942.7M-48.48%NA0.00%
BUY$40.2B127.94%75.8512.55%
BUY$107.9B99.08%25.1832.94%
NA$33.1BNA120.445.37%
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Cullinan Oncology LLC Stock including INR - Dollar returns

The Cullinan Oncology LLC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Cullinan Oncology LLC investment value today

Current value as on today

₹2,14,440

Returns

₹1,14,440

(+114.44%)

Returns from Cullinan Oncology LLC Stock

₹91,083 (+91.08%)

Dollar Impact

₹23,357 (+23.36%)

Analyst Recommendation on Cullinan Oncology LLC Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Cullinan Oncology LLC. Average target price of $31.63

Cullinan Oncology LLC Share Price Target

Get share price movements and forecasts by analysts on Cullinan Oncology LLC.

What analysts predicted

52.58%UPSIDE

Target Price

$31.63

Current Price

$15

Analyzed by

14 Analysts

Target

$31.63

Cullinan Oncology LLC target price $31.63, a slight upside of 52.58% compared to current price of $15. According to 14 analysts rating.

Indian Investors' Interest in Cullinan Oncology LLC Stock

Search interest for Cullinan Oncology LLC Stock has increased by 62% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:62% versus previous 30 day period

Cullinan Oncology LLC Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
0
Operating Income
-45
-45
-42
-50
-48
-55
-54
-75
-55
-55
EBITDA
-44
-45
-42
-49
-48
-54
-54
-75
-50
-60
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-39
-39
-37
-42
-40
-47
-48
-70
-50
-50
Income Tax Expense
-5
-14
0
-
-
0
-
-
-
-
Net Income
-39
-23
-37
-42
-40
-47
-48
-70
-50
-50
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cullinan Oncology LLC Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
18
18
-
-
-
-
Gross Profit
-
-
0
0
0
18
0
0
0
0
Operating Income
0
0
-14
-22
-60
-67
144
-191
-196
-241
EBITDA
-
-
-14
-22
-60
-67
-132
-190
-167
-241
Interest Expense
-
-
-
-
0
65
562
-
-
-
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
0
0
-14
-21
-59
-67
151
-169
-167
-219
Income Tax Expense
-
-
0
-1
-8
-2
42
-14
0
-
Net Income
0
0
-14
-20
-50
-65
111
-153
-167
-219
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-268.43%
-343.35%
0.00%
0.00%
0.00%
0.00%

Cullinan Oncology LLC Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-23
-37
-42
-40
-47
-48
-70
-50
-50
Operating Cash Flow
-18
-38
-36
-34
-36
-43
-57
-36
-38
Investing Cash Flow
51
12
-185
19
15
36
53
67
22
Financing Cash Flow
0
1
262
1
1
-
0
-
0
Change in Cash
33
-24
40
-12
-19
-6
-3
30
-15

Cullinan Oncology LLC Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-14
-20
-51
-67
109
-153
-167
-219
Operating Cash Flow
0
-13
-20
-29
-43
-126
-134
-145
-175
Investing Cash Flow
-
0
-35
-5
-333
248
35
-136
179
Financing Cash Flow
0
0
85
140
268
-25
40
266
1
Change in Cash
0
-13
29
104
-108
96
-57
-15
5

Global Institutional Holdings in Cullinan Oncology LLC

Funds
Holdings
MPM Oncology Impact Management LP
12.64%
Patient Square Capital
1.47%
BlackRock Inc
7.27%
Kynam Capital Management, LP
5.15%
Geode Capital Management, LLC
2.15%

Insights on Cullinan Oncology LLC

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CGEM stock has moved up by 14.5%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CGEM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CGEM has outperformed top 5 stocks with highest market-cap in its industry

About Cullinan Oncology LLC

Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmune diseases in Phase 1 clinical trials; Velinotamig, a BCMAxCD3 bispecific T cell in Phase 1 clinical trials in patients with autoimmune diseases; and CLN-049, a FLT3xCD3 bispecific T cell engager, which is in Phase 1 clinical trials in patients with relapsed and refractory acute myeloid leukemia or myelodysplastic syndrome. The company is also developing Zipalertinib, an orally available small-molecule, irreversible epidermal growth factor receptor inhibitor in Phase 2b portion of the REZILIENT1 clinical trial in patients with EGFR ex20ins non-small cell lung cancer. It has a license agreement with Chongqing Genrix Biopharmaceutical Co., Ltd to develop and commercialize velinotamig; a co-development agreement with Taiho Pharmaceutical Co., Ltd to develop zipalertinib; and a collaboration agreement with Adimab, LLC to discover and/or optimize antibodies. The company was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
OrganisationCullinan Oncology LLC
HeadquartersOne Main Street, Cambridge, MA, United States, 02142
IndustryBiotechnology
CEOMr. Nadim Ahmed M.S.
E-voting on sharesClick here to vote

Key Management of Cullinan Oncology LLC

Name

Title

Ms. Jacquelyn L. Sumer J.D.

Chief Legal Officer, Chief Compliance Officer & Corporate Secretary

Mr. Steve Andre

Chief Human Resources Officer

Mr. Kevin A. Johnston

Chief Technical Operations Officer

Dr. Patrick A. Baeuerle Ph.D.

Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board

Dr. Jeffrey Jones M.B.A., M.D., M.P.H.

Chief Medical Officer

Dr. Jennifer Michaelson Ph.D.

Chief Scientific Officer

Nicholas Smith

Head of Investor Relations

Dr. Corinne Savill Ph.D.

Chief Business Officer

Ms. Rose Weldon

Senior Vice President of Corporate Affairs

Mr. Nadim Ahmed M.S.

President, CEO & Director

FAQs

What is Cullinan Oncology LLC share price today?

Cullinan Oncology LLC share price today is $15 as on at the close of the market. Cullinan Oncology LLC share today touched a day high of $15.32 and a low of $14.55.

What is the 52 week high and 52 week low for Cullinan Oncology LLC share?

Cullinan Oncology LLC share touched a 52 week high of $16.74 on and a 52 week low of $5.68 on . Cullinan Oncology LLC stock price today i.e. is closed at $15,which is 10.39% down from its 52 week high and 164.08% up from its 52 week low.

What is Cullinan Oncology LLC's market capitalisation today?

Cullinan Oncology LLC market capitalisation is $0.00T as on .

How to invest in Cullinan Oncology LLC Stock (CGEM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cullinan Oncology LLC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cullinan Oncology LLC Shares that will get you 0.1000 shares as per Cullinan Oncology LLC share price of $15 per share as on May 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cullinan Oncology LLC Stock (CGEM) from India?

Indian investors can start investing in Cullinan Oncology LLC (CGEM) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Cullinan Oncology LLC stock (as per the Rupee-Dollar exchange rate as on ). Based on Cullinan Oncology LLC share’s latest price of $15 as on May 7, 2026 at 1:29 am IST, you will get 0.6667 shares of Cullinan Oncology LLC. Learn more about fractional shares .

What are the returns that Cullinan Oncology LLC has given to Indian investors in the last 5 years?

Cullinan Oncology LLC stock has given -48.48% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?